BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chung JH, Jung HR, Jung AR, Lee YC, Kong M, Lee JS, Eun YG. SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma. Sci Rep 2018;8:1677. [PMID: 29374236 DOI: 10.1038/s41598-018-20086-w] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Chuang HM, Huang MH, Chen YS, Harn HJ. SOX2 for Stem Cell Therapy and Medical Use: Pros or Cons? Cell Transplant 2020;29:963689720907565. [PMID: 32233795 DOI: 10.1177/0963689720907565] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pedregal-Mallo D, Hermida-Prado F, Granda-Díaz R, Montoro-Jiménez I, Allonca E, Pozo-Agundo E, Álvarez-Fernández M, Álvarez-Marcos C, García-Pedrero JM, Rodrigo JP. Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas. Cancers (Basel) 2020;12:E1794. [PMID: 32635524 DOI: 10.3390/cancers12071794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hsieh JC, Wang HM, Wu MH, Chang KP, Chang PH, Liao CT, Liau CT. Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy. Head Neck 2019;41 Suppl 1:19-45. [PMID: 31573749 DOI: 10.1002/hed.25932] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
4 Liu P, Tang H, Song C, Wang J, Chen B, Huang X, Pei X, Liu L. SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer. Front Pharmacol 2018;9:942. [PMID: 30186173 DOI: 10.3389/fphar.2018.00942] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
5 Shin SP, Goh AR, Kang HG, Kim SJ, Kim JK, Kim KT, Lee JH, Bae YS, Jung YS, Lee SJ. CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation. Cancers (Basel) 2019;11:E1583. [PMID: 31627350 DOI: 10.3390/cancers11101583] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
6 Peitzsch C, Nathansen J, Schniewind SI, Schwarz F, Dubrovska A. Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications. Cancers (Basel) 2019;11:E616. [PMID: 31052565 DOI: 10.3390/cancers11050616] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
7 Wolf GT, Winter W, Bellile E, Nguyen A, Donnelly CR, McHugh JB, Thomas D, Amlani L, Rozek L, Lei YL; Head and Neck SPORE Program. Histologic pattern of invasion and epithelial-mesenchymal phenotype predict prognosis in squamous carcinoma of the head and neck. Oral Oncol 2018;87:29-35. [PMID: 30527240 DOI: 10.1016/j.oraloncology.2018.10.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
8 Kołodziej-Rzepa M, Biesaga B, Janecka-Widła A, Mucha-Małecka A. Lack of CD44 and Sox-2 Overexpression as Two Independent Favourable Prognostic Factors in HPV Positive Patients with Oropharyngeal Cancers. Pathobiology 2022;:1-9. [PMID: 35078199 DOI: 10.1159/000521292] [Reference Citation Analysis]
9 Hamilton KL, Sheehan SA, Retzbach EP, Timmerman CA, Gianneschi GB, Tempera PJ, Balachandran P, Goldberg GS. Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways. J Cancer Res Clin Oncol 2021;147:445-57. [PMID: 33205348 DOI: 10.1007/s00432-020-03456-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Liang X, Deng M, Zhang C, Ping F, Wang H, Wang Y, Fan Z, Ren X, Tao X, Wu T, Xu J, Cheng B, Xia J. Combined class I histone deacetylase and mTORC1/C2 inhibition suppresses the initiation and recurrence of oral squamous cell carcinomas by repressing SOX2. Cancer Lett 2019;454:108-19. [PMID: 30981761 DOI: 10.1016/j.canlet.2019.04.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
11 Zhou Y, Sinha S, Schwartz JL, Adami GR. A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA. BMC Cancer 2019;19:607. [PMID: 31221127 DOI: 10.1186/s12885-019-5789-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
12 Hosseini-Khah Z, Babaei MR, Tehrani M, Cucchiarini M, Madry H, Ajami A, Rakhshani N, Rafiei A, Nikbin B. SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression. Curr Oncol 2021;28:3015-29. [PMID: 34436030 DOI: 10.3390/curroncol28040264] [Reference Citation Analysis]
13 Patel U, Kannan S, Rane SU, Mittal N, Gera P, Patil A, Manna S, Shejwal V, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB. Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab. Br J Cancer 2022. [PMID: 35140342 DOI: 10.1038/s41416-022-01730-9] [Reference Citation Analysis]
14 Gross-Cohen M, Yanku Y, Kessler O, Barash U, Boyango I, Cid-Arregui A, Neufeld G, Ilan N, Vlodavsky I. Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression. Matrix Biol 2021;99:58-71. [PMID: 34004353 DOI: 10.1016/j.matbio.2021.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Baumeister P, Hollmann A, Kitz J, Afthonidou A, Simon F, Shakhtour J, Mack B, Kranz G, Libl D, Leu M, Schirmer MA, Canis M, Belka C, Zitzelsberger H, Ganswindt U, Hess J, Jakob M, Unger K, Gires O. High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma. Sci Rep 2018;8:14582. [PMID: 30275505 DOI: 10.1038/s41598-018-32178-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
16 Wang S, Liu X, Chen Y, Zhan X, Wu T, Chen B, Sun G, Yan S, Xu L. The role of SOX2 overexpression in prognosis of patients with solid tumors: A meta-analysis and system review. Medicine (Baltimore) 2020;99:e19604. [PMID: 32221082 DOI: 10.1097/MD.0000000000019604] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cen WN, Pang JS, Huang JC, Hou JY, Bao WG, He RQ, Ma J, Peng ZG, Hu XH, Ma FC. The expression and biological information analysis of miR-375-3p in head and neck squamous cell carcinoma based on 1825 samples from GEO, TCGA, and peer-reviewed publications. Pathol Res Pract 2018;214:1835-47. [PMID: 30243807 DOI: 10.1016/j.prp.2018.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Porter L, McCaughan F. SOX2 and squamous cancers. Semin Cancer Biol 2020;67:154-67. [PMID: 32905832 DOI: 10.1016/j.semcancer.2020.05.007] [Reference Citation Analysis]
19 Zhou YX, Liu Q, Wang H, Ding F, Ma YQ. The expression and prognostic value of SOX2, β-catenin and survivin in esophageal squamous cell carcinoma. Future Oncol 2019;15:4181-95. [PMID: 31789057 DOI: 10.2217/fon-2018-0884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Chowdhury FN, Reisinger J, Gomez KE, Chimed TS, Thomas CM, Le PN, Miller B, Morton JJ, Nieto CM, Somerset HL, Wang XJ, Keysar SB, Jimeno A. Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function. Oral Oncol 2019;98:118-24. [PMID: 31586893 DOI: 10.1016/j.oraloncology.2019.09.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Seok J, Ryu CH, Ryu J, Kim JH, Lee SJ, Park WS, Jung YS. Prognostic Implication of SOX2 Expression Associated with p16 in Oropharyngeal Cancer: A Study of Consecutive Tissue Microarrays and TCGA. Biology (Basel) 2020;9:E387. [PMID: 33182283 DOI: 10.3390/biology9110387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Makarov V, Gorlin A. Meta-analysis of gene expression for development and validation of a diagnostic biomarker panel for Oral Squamous Cell Carcinoma. Computational Biology and Chemistry 2019;82:74-9. [DOI: 10.1016/j.compbiolchem.2019.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
23 Wang X, Ge X, Wang H, Huang J, Song Q, Xu C, Jiang Z, Su J, Wang H, Tan L, Jiang D, Hou Y. SOX2 amplification and chromosome 3 gain significantly impact prognosis in esophageal squamous cell carcinoma. Ann Transl Med 2021;9:321. [PMID: 33708948 DOI: 10.21037/atm-20-1290] [Reference Citation Analysis]
24 Vipparthi K, Patel AK, Ghosh S, Das S, Das C, Das K, Sarkar A, Thatikonda V, Pal B, Remani ASKN, Arora N, Parihar M, Vijayakumar MV, Bhat MK, Boppana R, Bhattacharjee S, Biswas NK, Arun P, Sharan R, Singh S. Two novel cell culture models of buccal mucosal oral cancer from patients with no risk-habits of tobacco smoking or chewing. Oral Oncol 2021;113:105131. [PMID: 33387705 DOI: 10.1016/j.oraloncology.2020.105131] [Reference Citation Analysis]
25 Gunduz M, Gunduz E, Tamagawa S, Enomoto K, Hotomi M. Cancer Stem Cells in Oropharyngeal Cancer. Cancers (Basel) 2021;13:3878. [PMID: 34359786 DOI: 10.3390/cancers13153878] [Reference Citation Analysis]
26 Tahmasebi E, Alikhani M, Yazdanian A, Yazdanian M, Tebyanian H, Seifalian A. The current markers of cancer stem cell in oral cancers. Life Sci 2020;249:117483. [PMID: 32135187 DOI: 10.1016/j.lfs.2020.117483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
27 Chuang YH, Lee CH, Lin CY, Liu CL, Huang SH, Lee JY, Chiu YY, Lee JC, Yang JM. An Integrated Genomic Strategy to Identify CHRNB4 as a Diagnostic/Prognostic Biomarker for Targeted Therapy in Head and Neck Cancer. Cancers (Basel) 2020;12:E1324. [PMID: 32455963 DOI: 10.3390/cancers12051324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]